Skip Navigation

Cardiovascular Research 1998 38(3):719-726; doi:10.1016/S0008-6363(98)00059-5
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bayraktutan, U.
Right arrow Articles by Shah, A. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayraktutan, U.
Right arrow Articles by Shah, A. M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat

Ulvi Bayraktutan, Zhao-Kang Yang and Ajay M Shah*

Department of Cardiology, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, UK

* Corresponding author. Tel.: +44 (1222) 742338; Fax: +44 (1222) 743500; E-mail: shaham2@cf.ac.uk

Objective: Recent studies indicate that endothelial type nitric oxide synthase (NOS3) modulates cardiac systolic and diastolic function and the inotropic responsiveness to β-adrenergic agonists, and may affect myocardial oxygen consumption. Although NOS3 is a constitutive protein, its levels of expression can be modified by various physiological and pathophysiological stimuli. We investigated whether the cell-specific expression of NOS3 mRNA and protein are altered in cardiac hypertrophy. Methods: Left ventricular cardiac myocytes and coronary microvascular endothelial cells were freshly isolated from 12 week old male spontaneously hypertensive rat (SHR) and matched normotensive Wistar rat hearts. NOS3 protein levels were assessed by Western analysis, and mRNA levels by RT-PCR and Southern blotting. Results: Left ventricular/body weight ratios were significantly increased in SHR compared to Wistar controls, indicating significant hypertrophy. The levels of NOS3 protein were markedly decreased in SHR compared to Wistar cardiac myocytes (by ~85%). By contrast, the expression of NOS3 mRNA normalized for GAPDH was increased ~3 fold in SHR cardiac myocytes relative to Wistar controls. In freshly isolated microvascular endothelial cells, however, levels of NOS3 protein and NOS3 mRNA were similar between the two groups. Conclusions: The expression of NOS3 is selectively altered in cardiac myocytes but not coronary microvascular endothelial cells of young SHR hearts, with a marked decrease in NOS3 protein but an increase in NOS3 mRNA. This dysregulation of NOS3 could contribute to contractile dysfunction in left ventricular hypertrophy.

KEYWORDS Experimental; Heart; Molecular biology; Hypertrophy; Myocytes; Endothelial factors; Hypertension; Nitric oxide; Rat


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
S. Wenzel, C. Rohde, S. Wingerning, J. Roth, G. Kojda, and K.-D. Schluter
Lack of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Formation Favors Hypertrophy in Adult Ventricular Cardiomyocytes
Hypertension, January 1, 2007; 49(1): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Zhao, D. Bell, L. R. Smith, L. Zhao, A. B. Devine, E. M. McHenry, D. P. Nicholls, and B. J. McDermott
Differential Expression of Components of the Cardiomyocyte Adrenomedullin/Intermedin Receptor System following Blood Pressure Reduction in Nitric Oxide-Deficient Hypertension
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1269 - 1281.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Bell, Y.-Y. Zhao, E. J. Kelso, E. M. McHenry, L. M. Rush, V. M. Lamont, D. P. Nicholls, and B. J. McDermott
Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H904 - H914.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
L. P. Thompson and Y. Dong
Chronic Hypoxia Decreases Endothelial Nitric Oxide Synthease Protein Expression in Fetal Guinea Pig Hearts
Reproductive Sciences, September 1, 2005; 12(6): 388 - 395.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
S. Ulker, D. McMaster, P. P. McKeown, and U. Bayraktutan
Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation
Cardiovasc Res, August 1, 2003; 59(2): 488 - 500.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
G. Li, Y. Xiao, J. L. Estrella, C. A. Ducsay, R. D. Gilbert, and L. Zhang
Effect of Fetal Hypoxia on Heart Susceptibility to Ischemia and Reperfusion Injury in the Adult Rat
Reproductive Sciences, July 1, 2003; 10(5): 265 - 274.
[Abstract] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. W. Cohen, D. S. Park, S. E. Woodman, T. M. Williams, M. Chandra, J. Shirani, A. Pereira de Souza, R. N. Kitsis, R. G. Russell, L. M. Weiss, et al.
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts
Am J Physiol Cell Physiol, February 1, 2003; 284(2): C457 - C474.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Piech, C. Dessy, X. Havaux, O. Feron, and J.-L. Balligand
Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats
Cardiovasc Res, February 1, 2003; 57(2): 456 - 467.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. C. Sampaio, J. E. Tanus-Santos, S. E. S. F. C. Melo, S. Hyslop, K. G. Franchini, I. M. Luca, and H. Moreno Jr
Hypertension Plus Diabetes Mimics the Cardiomyopathy Induced by Nitric Oxide Inhibition in Rats
Chest, October 1, 2002; 122(4): 1412 - 1420.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Ulker, P. P McKeown, and U. Bayraktutan
Aprotinin impairs coronary endothelial function and down-regulates endothelial NOS in rat coronary microvascular endothelial cells
Cardiovasc Res, September 1, 2002; 55(4): 830 - 837.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Piech, P. E. Massart, C. Dessy, O. Feron, X. Havaux, N. Morel, J.-L. Vanoverschelde, J. Donckier, and J.-L. Balligand
Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy
Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H219 - H231.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Grieve, P. A. MacCarthy, N. P. Gall, A. C. Cave, and A. M. Shah
Divergent Biological Actions of Coronary Endothelial Nitric Oxide During Progression of Cardiac Hypertrophy
Hypertension, August 1, 2001; 38(2): 267 - 273.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Chiappe de Cingolani, P. Morgan, C. Mundina-Weilenmann, J. Casey, J. Fujinaga, M. Camilion de Hurtado, and H. Cingolani
Hyperactivity and altered mRNA isoform expression of the Cl-/HCO3- anion-exchanger in the hypertrophied myocardium
Cardiovasc Res, July 1, 2001; 51(1): 71 - 79.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. J Paulus and A. M Shah
NO and cardiac diastolic function
Cardiovasc Res, August 15, 1999; 43(3): 595 - 606.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.